Literature DB >> 26999460

The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide.

R Crocchiolo1, L Castagna1, S Furst2, R Devillier2, B Sarina1, S Bramanti1, J El-Cheikh2, A Granata2, S Harbi2, L Morabito1, C Faucher2, A Rimondo1, D Girardi1, B Mohty2, B Calmels2, C Carlo-Stella1, C Chabannon2, R Bouabdallah2, A Santoro1, N Vey2, P J Weiller2, D Blaise2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26999460     DOI： 10.1038/bmt.2016.69

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.

Authors:  Per Ljungman; Ronald Brand; Jennifer Hoek; Rafael de la Camara; Catherine Cordonnier; Hermann Einsele; Jan Styczynski; Katherine N Ward; Simone Cesaro
Journal:  Clin Infect Dis       Date:  2014-05-20       Impact factor: 9.079

2.  Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall.

Authors:  M Noviello; A Forcina; V Veronica; R Crocchiolo; M T L Stanghellini; M Carrabba; R Greco; L Vago; F Giglio; A Assanelli; M R Carbone; Z Magnani; F Crippa; C Corti; M Bernardi; J Peccatori; C Bordignon; F Ciceri; C Bonini; A Bondanza
Journal:  Bone Marrow Transplant       Date:  2015-06-15       Impact factor: 5.483

3.  Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

Authors:  Alessandra Roberto; Luca Castagna; Veronica Zanon; Stefania Bramanti; Roberto Crocchiolo; James E McLaren; Sara Gandolfi; Paolo Tentorio; Barbara Sarina; Inna Timofeeva; Armando Santoro; Carmelo Carlo-Stella; Benedetto Bruno; Cristiana Carniti; Paolo Corradini; Emma Gostick; Kristin Ladell; David A Price; Mario Roederer; Domenico Mavilio; Enrico Lugli
Journal:  Blood       Date:  2015-03-05       Impact factor: 22.113

4.  Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients.

Authors:  G Venton; R Crocchiolo; S Fürst; A Granata; C Oudin; C Faucher; D Coso; R Bouabdallah; P Berger; N Vey; P Ladaique; C Chabannon; M le Merlin; D Blaise; J El-Cheikh
Journal:  Clin Microbiol Infect       Date:  2013-04-22       Impact factor: 8.067

5.  Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors.

Authors:  L Castagna; R Crocchiolo; S Furst; J El-cheikh; B Esterni; A Granata; A Stoppa; R Boubdallah; D Coso; N Vey; A Charbonnier; C Lemarie; C Faucher; C Chabannon; D Blaise
Journal:  Bone Marrow Transplant       Date:  2014-07-07       Impact factor: 5.483

6.  Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients.

Authors:  Alejandra Ugarte-Torres; Mette Hoegh-Petersen; Yiping Liu; Feng Zhou; Tyler S Williamson; Diana Quinlan; Sarah Sy; Lina Roa; Faisal Khan; Kevin Fonseca; James A Russell; Jan Storek
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-03       Impact factor: 5.742

Review 7.  Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation.

Authors:  Jan Storek; Mohamad Mohty; Jaap Jan Boelens
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-05       Impact factor: 5.742

8.  Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality.

Authors:  S Matthes-Martin; T Lion; S W Aberle; G Fritsch; A Lawitschka; B Bittner; F Frommlet; H Gadner; C Peters
Journal:  Bone Marrow Transplant       Date:  2003-05       Impact factor: 5.483

9.  Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

Authors:  Luca Castagna; Roberto Crocchiolo; Sabine Furst; Stefania Bramanti; Jean El Cheikh; Barbara Sarina; Angela Granata; Elisa Mauro; Catherine Faucher; Bilal Mohty; Samia Harbi; Christian Chabannon; Carmelo Carlo-Stella; Armando Santoro; Didier Blaise
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-13       Impact factor: 5.742

10.  Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.

Authors:  Didier Blaise; Sabine Fürst; Roberto Crocchiolo; Jean El-Cheikh; Angela Granata; Samia Harbi; Reda Bouabdallah; Raynier Devillier; Stephania Bramanti; Claude Lemarie; Christophe Picard; Christian Chabannon; Pierre-Jean Weiller; Catherine Faucher; Bilal Mohty; Norbert Vey; Luca Castagna
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-01       Impact factor: 5.742
View more
  8 in total

1.  Feasibility and Efficacy of Partially Replacing Post-Transplantation Cyclophosphamide with Bendamustine in Pediatric and Young Adult Patients Undergoing Haploidentical Bone Marrow Transplantation.

Authors:  Emmanuel Katsanis; Baldassarre Stea; Kristen Kovacs; Laurel Truscott; Muhammad Husnain; Sharad Khurana; Denise J Roe; Richard J Simpson
Journal:  Transplant Cell Ther       Date:  2022-04-20

2.  Progressive substitution of posttransplant cyclophosphamide with bendamustine: A phase I study in haploidentical bone marrow transplantation.

Authors:  Emmanuel Katsanis; Keri Maher; Denise J Roe; Richard J Simpson
Journal:  EJHaem       Date:  2020-05-26

3.  Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.

Authors:  Jacopo Mariotti; Anna Maria Raiola; Andrea Evangelista; Angelo Michele Carella; Massimo Martino; Francesca Patriarca; Antonio Risitano; Stefania Bramanti; Alessandro Busca; Luisa Giaccone; Lucia Brunello; Emanuela Merla; Lucia Savino; Barbara Loteta; Giuseppe Console; Renato Fanin; Alessandra Sperotto; Luana Marano; Serena Marotta; Camilla Frieri; Simona Sica; Patrizia Chiusolo; Samia Harbi; Sabine Furst; Armando Santoro; Andrea Bacigalupo; Didier Blaise; Emanuele Angelucci; Domenico Mavilio; Luca Castagna; Benedetto Bruno
Journal:  Blood Adv       Date:  2020-08-25

Review 4.  The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation.

Authors:  Stefan O Ciurea; Monzr M Al Malki; Piyanuch Kongtim; Ephraim J Fuchs; Leo Luznik; Xiao-Jun Huang; Fabio Ciceri; Franco Locatelli; Franco Aversa; Luca Castagna; Andrea Bacigalupo; Massimo Martelli; Didier Blaise; Patrick Ben Soussan; Yolande Arnault; Rupert Handgretinger; Denis-Claude Roy; Paul V O'Donnell; Asad Bashey; Scott Solomon; Rizwan Romee; Jorge Gayoso; Hillard M Lazarus; Karen Ballen; Bipin N Savani; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2019-03-04       Impact factor: 5.483

5.  Expect the unexpected.

Authors:  Didier Blaise
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

Review 6.  Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.

Authors:  Elisa Zaghi; Michela Calvi; Clara Di Vito; Domenico Mavilio
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

Review 7.  CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update.

Authors:  Xiao-Hua Luo; Yan Zhu; Yu-Ting Chen; Li-Ping Shui; Lin Liu
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

8.  A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation.

Authors:  Meng-Zhu Shen; Shen-Da Hong; Jie Wang; Xiao-Hui Zhang; Lan-Ping Xu; Yu Wang; Chen-Hua Yan; Huan Chen; Yu-Hong Chen; Wei Han; Feng-Rong Wang; Jing-Zhi Wang; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Dong Mo
Journal:  Front Cell Infect Microbiol       Date:  2022-03-22       Impact factor: 5.293
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.